Equator Therapeutics
Develops a drug to burn calories and improve metabolism.
Employees
Market cap
-
Enterprise valuation
CAD818k—1m (Dealroom.co estimates Mar 2020.)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$150k | Seed | ||
* | $500k | Early VC | |
Total Funding | CAD886k |
Related Content
Recent News about Equator Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.